{"nct_id":"NCT03104400","title":"A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Participants With Psoriatic Arthritis Who Have an Inadequate Response to at Least One Non-Biologic Disease Modifying Anti-Rheumatic Drug (DMARD)","status":"COMPLETED","status_verified_date":"2025-09","start_date":"2017-04-27","start_date_type":"ACTUAL","primary_completion_date":"2019-09-26","primary_completion_date_type":"ACTUAL","completion_date":"2024-09-09","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["ABBV"]}